Vitamin K1 (Phytonadione)

Vitamin K is the formula ingredient most clinically connected to a parental decision happening in the delivery room, whether the newborn receives the universal vitamin K injection administered at birth in US and EU hospitals. Both EU and US infant formula regulation require vitamin K1 (phytonadione) because newborn vitamin K deficiency is one of the few neonatal deficiencies that can cause life-threatening intracranial hemorrhage in otherwise healthy infants.

What vitamin K does

Vitamin K is essential for the post-translational modification of proteins involved in blood clotting (factors II, VII, IX, X, and proteins C and S) and in bone mineralization. Without adequate vitamin K, these proteins can't be activated, and the blood-clotting cascade fails.

Two natural forms exist:

• Vitamin K1 (phytonadione), found in green leafy vegetables and used in infant formula and the neonatal injection. The form most directly utilized by the liver for clotting factor activation.
• Vitamin K2 (menaquinones), produced by gut bacteria; secondary biological role in bone health and arterial function. Not directly supplemented in standard infant formula.

In infant formula, vitamin K is supplied as K1 (phytonadione), the form with the most direct effect on clotting factor activation.

Why newborns are vulnerable

Newborns are born with low vitamin K because:

• Placental transfer is limited. Maternal vitamin K crosses the placenta poorly compared to most fat-soluble vitamins.
• Sterile gut at birth. Gut bacteria that produce vitamin K2 colonize over the first weeks of life; newborns initially produce little endogenous K.
• Breast milk has low vitamin K. Maternal breast milk K1 content is ~1 µg/L, well below adequate intake. Formula-fed infants get 5-10× more.
• Liver immaturity. Newborn liver clotting factor synthesis is somewhat reduced regardless of K status.

The combination produces the unique newborn vitamin K vulnerability that drove universal K shot policy.

Vitamin K deficiency bleeding (VKDB)

VKDB has three forms by timing:

• Early VKDB (first 24 hours), usually from maternal medication (anticonvulsants, anticoagulants); rare with modern obstetric monitoring.
• Classic VKDB (days 2-7), historically common in unsupplemented newborns; prevented by universal K shot.
• Late VKDB (weeks 2-12), most dangerous form; ~50% present with intracranial hemorrhage. Predominantly affects breastfed infants who didn't receive the K shot at birth.

The K shot at birth provides 1 mg of vitamin K1 IM, which provides protection through the first months when endogenous K2 production from gut flora becomes adequate.

Formula's role

Per EU Regulation 2016/127 and FDA 21 CFR 107.100, infant formula must provide vitamin K1 at 1-25 µg/100 kcal (typically 4-8 µg/100 kcal in current formulations). At typical feeding volumes, this delivers approximately 50-100 µg/day to a 6-month-old infant, well above the 2 µg/day adequate intake estimate.

The high formula K1 content is why formula-fed infants who don't receive the K shot have meaningfully lower VKDB risk than unshot breastfed infants, though both are at risk vs shot-receiving counterparts. AAP and EU pediatric guidance still strongly recommend the universal K shot regardless of feeding method.

What this means for families

For formula-fed infants who received the standard K shot at birth, vitamin K is fully covered, formula content + endogenous bacterial production after gut colonization meet ongoing needs without specific concern. For breastfed infants who didn't receive the K shot, late VKDB risk is real and the clinical guidance is to administer the shot or pursue alternative prophylactic protocols under pediatric supervision. Per AAP guidance, the K shot is one of the highest-evidence neonatal interventions in modern medicine, refusing it is a meaningful clinical decision warranting discussion with the pediatrician.

The formula vitamin K content is regulatory-mandated and consistent across brands, not a meaningful differentiator between formulas. The clinically relevant decisions are the K shot at birth and whether the infant is formula-fed or breastfed.

Why oral vitamin K isn't a substitute for the IM shot

A periodically resurfacing question from families considering refusing the K shot is whether oral vitamin K supplementation can substitute. The clinical answer per AAP and pediatric hematology guidance is "not adequately." Oral vitamin K protocols (multiple doses over weeks) provide partial protection against early and classic VKDB but have inadequate evidence for late VKDB prevention, the most dangerous form. Some European countries (Netherlands, Denmark) use oral protocols, but they typically require 3-6 doses across the first months and have higher rates of VKDB compared to single-dose IM shot practice. The IM injection is one-and-done with reliable absorption; oral protocols depend on absorption, parental compliance with multiple doses, and infant retention of the dose.

The K shot itself has been thoroughly studied for safety, the 1990 study that briefly suggested cancer association was retracted/refuted by multiple larger subsequent studies showing no association. The intervention has one of the strongest safety profiles in modern neonatal medicine.

Vitamin K2 (menaquinones), the bone-and-cardiovascular angle

Some infant nutrition discussions raise vitamin K2, a separate form of vitamin K with documented roles in bone mineralization (via osteocalcin activation) and arterial calcification prevention (via matrix Gla protein activation). Standard infant formula doesn't add vitamin K2 because:

• Infants synthesize K2 endogenously after gut bacterial colonization
• Adequate K1 intake supports the body's K2 conversion capacity in those tissues that need it
• The clinical evidence base for adding K2 to infant formula specifically is not yet substantial enough to drive regulatory action

Some emerging premium formulas may include K2 alongside K1; this is a recent trend without long-term clinical evidence to support it as definitively beneficial.

Frequently asked questions

Related reading

• Vitamin D3 ingredient explainer
• Vitamin C ingredient explainer
• Iron ingredient explainer
• Best formula for newborns
• Best baby formulas

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.